Kejie Zhang

Xiamen, 361004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Journal: MedScience

Published: August 06, 2025

Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study.

Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study.

Journal: International journal of cardiology

Published: March 08, 2024

Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.

Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.

Journal: Thrombosis journal

Published: October 15, 2022

Development and validation of a nomogram for steroid-resistance prediction in immune thrombocytopenia patients.

Development and validation of a nomogram for steroid-resistance prediction in immune thrombocytopenia patients.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 06, 2021

Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report.

Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report.

Journal: Medicine

Published: October 13, 2021

CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.

CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.

Journal: Medicine

Published: August 12, 2021

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma.

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma.

Journal: Cancer cell international

Published: March 22, 2021

Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

Journal: Medicine

Published: July 03, 2019

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting.

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting.

Journal: Oncotarget

Published: March 25, 2016

Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report.

Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report.

Journal: Experimental and therapeutic medicine

Published: February 26, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026